Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $54.1 million.

  • Fortress Biotech's Total Current Liabilities fell 2309.65% to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year decrease of 2309.65%. This contributed to the annual value of $71.4 million for FY2024, which is 1591.02% down from last year.
  • Fortress Biotech's Total Current Liabilities amounted to $54.1 million in Q3 2025, which was down 2309.65% from $57.5 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Total Current Liabilities registered a high of $129.5 million during Q1 2023, and its lowest value of $53.8 million during Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $87.7 million (2024), whereas its average is $89.5 million.
  • As far as peak fluctuations go, Fortress Biotech's Total Current Liabilities surged by 17685.15% in 2021, and later crashed by 4124.96% in 2024.
  • Fortress Biotech's Total Current Liabilities (Quarter) stood at $101.0 million in 2021, then rose by 26.4% to $127.7 million in 2022, then tumbled by 33.52% to $84.9 million in 2023, then decreased by 15.91% to $71.4 million in 2024, then decreased by 24.27% to $54.1 million in 2025.
  • Its Total Current Liabilities was $54.1 million in Q3 2025, compared to $57.5 million in Q2 2025 and $73.7 million in Q1 2025.